Literature DB >> 23998978

Management of the patient with incomplete response to PPI therapy.

Peter J Kahrilas1, Guy Boeckxstaens, Andre J P M Smout.   

Abstract

Proton pump inhibitors (PPIs) remove most of the acid from the gastroesophageal refluxate. However, PPIs do not eliminate reflux and the response of specific GERD symptoms to PPI therapy depends on the degree to which acid drives those symptoms. PPIs are progressively less effective for heartburn, regurgitation, chest pain and extra-oesophageal symptoms. Hence, with an incomplete PPI response, obtaining an accurate history, detailing which symptoms are 'refractory' and exactly what evidence exists linking these symptoms to GERD is paramount. Reflux can continue to cause symptoms despite PPI therapy because of persistent acid reflux or weakly acidic reflux. Given these possibilities, diagnostic testing (pH or pH-impedance monitoring) becomes essential. Antireflux surgery is an alternative in patients if a clear relationship is established between persistent symptoms, particularly regurgitation, and reflux. Treating visceral hypersensitivity may also benefit the subset of GERD patients whose symptoms are driven by this mechanism.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ambulatory oesophageal pH monitoring; Ambulatory oesophageal pH-impedance monitoring; Gastroesophageal reflux disease; Oesophagus; Proton pump inhibitors; Visceral hypersensitivity

Mesh:

Substances:

Year:  2013        PMID: 23998978      PMCID: PMC3761380          DOI: 10.1016/j.bpg.2013.06.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  78 in total

1.  Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.

Authors:  J G Hatlebakk; P O Katz; L Camacho-Lobato; D O Castell
Journal:  Aliment Pharmacol Ther       Date:  2000-10       Impact factor: 8.171

2.  Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.

Authors:  N T Gunaratnam; T P Jessup; J Inadomi; D P Lascewski
Journal:  Aliment Pharmacol Ther       Date:  2006-05-15       Impact factor: 8.171

3.  Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.

Authors:  John M Inadomi; Lisa McIntyre; Latoya Bernard; A Mark Fendrick
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

Review 4.  Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.

Authors:  Peter J Kahrilas; Nesta Hughes; Colin W Howden
Journal:  Gut       Date:  2011-04-20       Impact factor: 23.059

5.  Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period.

Authors:  W O Rohof; R J Bennink; A A de Ruigh; D P Hirsch; A H Zwinderman; G E Boeckxstaens
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

Review 6.  Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease.

Authors:  G E Boeckxstaens; A Smout
Journal:  Aliment Pharmacol Ther       Date:  2010-05-18       Impact factor: 8.171

7.  Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia.

Authors:  R K Mittal; R C Lange; R W McCallum
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

8.  A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.

Authors:  Peter J Kahrilas; John Dent; Karsten Lauritsen; Peter Malfertheiner; Hans Denison; Stefan Franzén; Goran Hasselgren
Journal:  Clin Gastroenterol Hepatol       Date:  2007-10-22       Impact factor: 11.382

9.  A comparison of five maintenance therapies for reflux esophagitis.

Authors:  S Vigneri; R Termini; G Leandro; S Badalamenti; M Pantalena; V Savarino; F Di Mario; G Battaglia; G S Mela; A Pilotto
Journal:  N Engl J Med       Date:  1995-10-26       Impact factor: 91.245

10.  Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial.

Authors:  L Lundell; S Attwood; C Ell; R Fiocca; J-P Galmiche; J Hatlebakk; T Lind; O Junghard
Journal:  Gut       Date:  2008-05-09       Impact factor: 23.059

View more
  21 in total

Review 1.  Diagnosis and Management of Functional Heartburn.

Authors:  Christine Hachem; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

2.  Hypnotherapy for Esophageal Disorders.

Authors:  Megan E Riehl; Laurie Keefer
Journal:  Am J Clin Hypn       Date:  2015-07

Review 3.  Advances in the Diagnosis and Treatment of GERD: New Tricks for an Old Disease.

Authors:  Rishi D Naik; Lauren Evers; Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

Review 4.  Management of refractory typical GERD symptoms.

Authors:  Emidio Scarpellini; Daphne Ang; Ans Pauwels; Adriano De Santis; Tim Vanuytsel; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-14       Impact factor: 46.802

Review 5.  Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.

Authors:  Rena Yadlapati; Kelli DeLay
Journal:  Med Clin North Am       Date:  2018-11-01       Impact factor: 5.456

6.  Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

Authors:  Mohammad Bashashati; Reza A Hejazi; Christopher N Andrews; Martin A Storr
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04-09

7.  Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

Authors:  Shobna J Bhatia; Govind K Makharia; Philip Abraham; Naresh Bhat; Ajay Kumar; D Nageshwar Reddy; Uday C Ghoshal; Vineet Ahuja; G Venkat Rao; Krishnadas Devadas; Amit K Dutta; Abhinav Jain; Saurabh Kedia; Rohit Dama; Rakesh Kalapala; Jose Filipe Alvares; Sunil Dadhich; Vinod Kumar Dixit; Mahesh Kumar Goenka; B D Goswami; Sanjeev K Issar; Venkatakrishnan Leelakrishnan; Mohandas K Mallath; Philip Mathew; Praveen Mathew; Subhashchandra Nandwani; Cannanore Ganesh Pai; Lorance Peter; A V Siva Prasad; Devinder Singh; Jaswinder Singh Sodhi; Randhir Sud; Jayanthi Venkataraman; Vandana Midha; Amol Bapaye; Usha Dutta; Ajay K Jain; Rakesh Kochhar; Amarender S Puri; Shivram Prasad Singh; Lalit Shimpi; Ajit Sood; Rajkumar T Wadhwa
Journal:  Indian J Gastroenterol       Date:  2019-12-05

8.  Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias.

Authors:  Kais A Rona; Jessica Reynolds; Katrin Schwameis; Joerg Zehetner; Kamran Samakar; Paul Oh; David Vong; Kulmeet Sandhu; Namir Katkhouda; Nikolai Bildzukewicz; John C Lipham
Journal:  Surg Endosc       Date:  2016-08-23       Impact factor: 4.584

9.  QX-314 inhibits acid-induced activation of esophageal nociceptive C fiber neurons.

Authors:  Youtian Hu; Xiaoyun Yu; Shaoyong Yu
Journal:  Neurogastroenterol Motil       Date:  2019-01-20       Impact factor: 3.598

10.  Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.

Authors:  Rena Yadlapati; Melina Masihi; C Prakash Gyawali; Dustin A Carlson; Peter J Kahrilas; Billy Darren Nix; Anand Jain; Joseph R Triggs; Michael F Vaezi; Leila Kia; Alexander Kaizer; John E Pandolfino
Journal:  Gastroenterology       Date:  2020-09-16       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.